Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency recommends suspension of marketing authorisation of aprotinin-containing medicines for systemic use 21 Νοέμβριος 2007Press releaseHumanMedicines Novartis withdraws its application to extend the marketing authorisation for Zometa 20 Νοέμβριος 2007Press releaseHuman Public statement on the cessation of marketing of exubera (Insulin human) 19 Νοέμβριος 2007NewsHuman INFAI withdraws its marketing authorisation application for Gastromotal 16 Νοέμβριος 2007Press releaseHuman European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products 16 Νοέμβριος 2007Press releaseHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use,12-15 November 2007 16 Νοέμβριος 2007Press releaseHuman European Medicines Agency recommends changes in the product information for Protelos / Osseor due to the risk of severe hypersensitivity reactions 16 Νοέμβριος 2007Press releaseHumanMedicines Committee for medicinal products for veterinary use: Meeting of 6-8 November 2007 9 Νοέμβριος 2007Press releaseVeterinary First Global Animal Health Conference to enhance positive environment for veterinary medicines 8 Νοέμβριος 2007Press releaseVeterinary Committee on herbal medicinal products: Elects new chair and vice-chair 31 Οκτώβριος 2007Press releaseHerbal 1 … 318 319 320 321 322 Page 322 of 384 323 324 325 326 … 384
European Medicines Agency recommends suspension of marketing authorisation of aprotinin-containing medicines for systemic use 21 Νοέμβριος 2007Press releaseHumanMedicines
Novartis withdraws its application to extend the marketing authorisation for Zometa 20 Νοέμβριος 2007Press releaseHuman
INFAI withdraws its marketing authorisation application for Gastromotal 16 Νοέμβριος 2007Press releaseHuman
European Medicines Agency recommends suspension of marketing authorisations for carisoprodol-containing medicinal products 16 Νοέμβριος 2007Press releaseHumanMedicines
Meeting highlights from the Committee for Medicinal Products for Human Use,12-15 November 2007 16 Νοέμβριος 2007Press releaseHuman
European Medicines Agency recommends changes in the product information for Protelos / Osseor due to the risk of severe hypersensitivity reactions 16 Νοέμβριος 2007Press releaseHumanMedicines
Committee for medicinal products for veterinary use: Meeting of 6-8 November 2007 9 Νοέμβριος 2007Press releaseVeterinary
First Global Animal Health Conference to enhance positive environment for veterinary medicines 8 Νοέμβριος 2007Press releaseVeterinary
Committee on herbal medicinal products: Elects new chair and vice-chair 31 Οκτώβριος 2007Press releaseHerbal